The unfinished Australian jigsaw puzzle – Prof Jeffrey Braithwaite

As 1st April 2020 dawned in Australia, I realised it was April Fool’s day. But it wasn’t pranks from my children, friends or colleagues that I was immediately on alert about. It was what everyone does these days, in this era of the coronavirus.

As 1st April 2020 dawned in Australia, I realised it was April Fool’s day. But it wasn’t pranks from my children, friends or colleagues that I was immediately on alert about. It was what everyone does these days, in this era of the coronavirus. It was to see what was happening to the world – like every other day these last few weeks, but with increasing concern.  Quickly scanning my smartphone’s news feed, I read that a 95-year-old woman – someone’s mother, grandmother, friend – had died from COVID-19. This took the Australian death toll to 20 and it will sadly and inevitably be higher by the time you read this.

At 6am on 1st April there were 4,707 confirmed cases of COVID-19 in Australia, rising by 348 in less than 24 hours.

The Australian numbers are moderate in comparison with many parts of the world. I worry especially about our wonderful colleagues on the clinical frontlines in Italy, Spain and Iran, our neighbours in China and our friends across the Pacific, in the USA, where cases are accelerating rapidly.

But Australians are keenly aware of their position on the timeline. We are two weeks behind what is happening in European countries and must learn from their experience – and those across the Pacific and south east Asian region. No-one should forget that Italy raced from 463 deaths to 1,441 in just six days in early March. But neither should we forget that Singapore, Hong Kong and others have slowed the rate, and Wuhan in China, with a monumental effort, has curved downward.

The Australian government reportedly has the highest per capita rate of testing for COVID-19 in the world, with more than 250,000 tests having been carried out. It’s reassuring to hear but hard to gauge the accuracy of this call, as other countries are obviously doing lots of testing, as recommended by our amazing colleagues in the WHO.

Australia did move relatively quickly to close the borders first to China, then Iran, then South Korea and Italy. By 20th March, the borders were closed further, allowing in only citizens, permanent residents and their immediate family. All international travel out of Australia has now been stopped.

Australia is lucky though – it is a very large country-in-a-continent, and shares no borders with anyone. Many other countries would feel fortunate in a pandemic if their country was surrounded by seas.

Australia has been subject to escalating isolation requirements. This began with a request for people to voluntarily self-isolate at home if feeling unwell. Soon afterwards the policy came out that everyone should work or study from home if possible. Now people returning from overseas are met at the airport and taken to hotels for a mandatory quarantine period of 14 days – because when it was voluntary, not everyone did the right thing.

Australia has also made mistakes.

On 19th March, a cruise ship, the Ruby Princess, docked in the harbour at Circular Quay, in the very centre of Sydney. Over 2,700 passengers were allowed to disembark and quickly dispersed to various parts of Australia and back to their own countries, some flying back to homes in the USA. Very quickly – but not quickly enough – it came to light that some passengers had been tested for COVID-19 while on board, but authorities did not wait for the results before allowing most passengers to disembark.

Since then 440 passengers from the cruise ship, now scattered over various parts of Australia, have tested positive to the virus. Disconcertedly, one passenger unwittingly took COVID-19 into the Northern Territory at the top end of Australia, home to large and vulnerable Aboriginal populations.

Looking ahead more positively, the Federal Government has announced a plan to alleviate the pressure on the public health system and access more hospital beds and equipment by working with the more than 650 private hospitals. It’s a partnership that was unheard of only six weeks ago, but now has been made possible. (It reminds me of that famous proverb, wrongly attributed to Plato, but which is thought to be Latin – “Mater artium necessitas”, or “necessity is the mother of invention.”)

Under this arrangement, private hospitals will take patients from the public system, provide much needed additional intensive care beds and share their stocks of personal protective equipment which are in short supply in the public system. It’s the kind of collaborative approach to the health system that I and many of my colleagues have advocated over many years.

All-in-all, it’s a bit of an unfinished Australian jigsaw puzzle. In truth, only time will tell how well Australia fares in this crisis. But as I read the news on this fine April Fool’s day, it occurred to me that it’s an incomplete picture everywhere. So much uncertainty, so many of the jigsaw puzzle pieces are yet to be snapped into place.


Author: Professor Jeffrey Braithwaite, Founding Director of the Australian Institute of Health Innovation, Director of the Centre for Healthcare Resilience and Implementation Science and Professor of Health Systems Research at Macquarie University; and President-Elect of the International Society for Quality in Health Care.

Recent Blog Articles

Stay in Touch

We bring you the latest research, expert opinions, and industry updates in healthcare safety and quality – so you’re always in the know.

Follow us on social media

Nourhan Kawtharani


Nourhan, a quality and safety coordinator with eight years of experience in ambulatory healthcare in Lebanon, aims to deepen her understanding of the systemic and holistic approach to healthcare through this fellowship.

She aims to identify gaps and develop tailored interventions that address specific contexts rather than applying general solutions. Engaging with diverse professionals and perspectives during this educational journey will expand the application of these concepts across different cultural settings.

Nourhan emphasizes the importance of promoting a culture of continuous learning and improvement within healthcare institutions, considering it a vital leadership responsibility to integrate quality and safety initiatives into the organizational culture.

Nourhan's commitment to patient safety and quality management includes sourcing practical resources and transforming insights into actionable knowledge to drive continued progress in healthcare practices and outcomes.

This will close in 0 seconds

Elom Otchi


Elom is passionate about improving quality of care and patient safety outcomes.

In view of this, he has had the opportunity to work in various capacities with various organisations including AfIHQSA, WHO, UNICEF and others undertaking research, supporting the development of national quality policies and strategies, facilitating the establishment of quality governance systems across all the levels of the health sector and building capacity of national and sub-national quality leads/teams to institutionalize the practice of quality and patient safety across the continent.

He has also worked extensively across all levels of care in the health sector of Ghana, including leading the Quality & Patient Safety program in its largest teaching hospital.

I would like to use this Fellowship as a learning platform and an opportunity to acquire the requisite knowledge, skills and competencies to complement ongoing efforts by like-minded individuals and organizations to continuously advance improve the quality and patient safety in Ghana and the continent.

This will close in 0 seconds

Stephen Taiye Balogun


Stephen is a Senior Programme Officer at the Institute of Human Virology in Nigeria as well as Country Representative for Health Information for All (HIFA).

Stephen plans to use this opportunity to maximise his impact by championing the cause of patient safety and quality in Nigeria and across Africa.

Stephen says "Quality and safety is a major wheel through which universal healthcare coverage can be achieved. The goal is to be a bridge in the gap between the International Quality Improvement and Patient Safety community and my country to ensure rapid spread, adoption, implementation and practice."

We are looking forward to working with both Stephen and our 2020 winner Rhoda Kalondu over the next year.

This will close in 0 seconds

Dr Rhoda Kalondu


Rhoda is the Head of the Patient Safety Unit at Kenyatta Hospital in Nairobi and wants to use this Fellowship to learn how to establish a culture of safety and develop systems for assessment and analysis at her institution, and more widely. As well as this, Rhoda intends to develop and execute an intervention to improve patient safety in Kenyatta National Hospital.

It is one thing to institute measures and processes for improvement, but quite another to change the culture of an environment. Rhoda's ambition to lead others in this change inspired the panel.

This will close in 0 seconds

Dr Subhrojyoti Bhowmick


I am an MBBS graduate from Calcutta University with a Gold Medal in Gynecology & Obstetrics.

I have completed M.D in Pharmacology from IPGME& R, Kolkata and have over 12 years of experience in the field of Clinical Research, Pharmacovigilance and Medication management in Hospitals.

I have completed certification in Clinical Research Administration & Project Management from Stanford University, USA and in Patient Safety from Johns Hopkins University, USA.

I am an Assessor for National Accreditation Board for Hospitals & Health care providers (NABH), India assessing hospitals for medication safety and clinical quality standards and NABH Assessor for Ethics Committee Accreditation program in India as well.

I serve as the Chairperson, Institutional Ethics Committee of Health Point Hospital, Kolkata and am associated with 2 other Hospital ethics committees as a member.

I finished my Fellowship in Healthcare Quality from the International Society of Quality in Healthcare (ISQua) from Ireland in 2017.

I have published several research articles and have also authored a chapter on “Regulations governing Clinical Trial” in the book “Fundamentals of Clinical Trial & Research”.

I am a peer reviewer for prestigious international journals like the British Journal of Clinical Pharmacology, CNS Drugs and Drug Safety case reports.

I am the recipient of the UK Seth Oration Award for Best Clinical Pharmacology paper by the Indian Pharmacological Society in 2009 and the “Most promising Healthcare professional in Patient Safety in India” award by the Asian African Chamber of Commerce and Industry in October 2018.

Recently in April 2019, I received the Young Quality Achiever award by Consortium of Accredited Healthcare Organizations (CAHO), India for 2019 for my work in the field of medication safety and clinical research.

I have a keen interest in teaching and am visiting adjunct faculty of Pharmacology at KMC, Mangalore, India and for Healthcare technology at MAKAUT, Kolkata, India.

I was associated with Stanford University School of Medicine, in the USA as a Senior Clinical Research Associate from 2015 to 2017 and have certification in Biostatistics, Evidence-based Medicine and Medical Writing from Stanford University.

Currently, I am working as the Clinical Director of Academics, Medical Quality and Clinical Research at Peerless Hospital and B K Roy Research Centre, Kolkata.

I am very happy and thrilled to receive the prestigious ISQua Lucian Leape Patient safety Fellowship Award for 2019 and I look forward to honing my skills further in the field of healthcare quality and patient safety through my experiences during this fellowship.

I sincerely believe that successful completion of this fellowship will help me evolve as a more confident Patient safety leader in India who in turn can provide significant inputs on policy changes through NABH for the Indian healthcare system.

This will close in 0 seconds